| P2093 | author name string | Ahmed M Abu El-Asrar | |
| P2860 | cites work | Resistance of retinal inflammatory mediators to suppress after reinstitution of good glycemic control: novel mechanism for metabolic memory | Q24647760 |
| | Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression | Q28192264 |
| | Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats | Q28213026 |
| | Matrix metalloproteinases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier | Q28235057 |
| | Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial cells: significance of core 2 GlcNAc-T in diabetic retinopathy | Q28289690 |
| | Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice | Q28345267 |
| | Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine | Q28505149 |
| | Matrix metalloproteinases in human diabetic and nondiabetic vitreous | Q32058683 |
| | A permissive role for tumor necrosis factor in vascular endothelial growth factor-induced vascular permeability. | Q32061774 |
| | Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy | Q33303988 |
| | TNF primes endothelial cells for angiogenic sprouting by inducing a tip cell phenotype | Q33323527 |
| | Association of vitreous inflammatory factors with diabetic macular edema | Q33396882 |
| | High-mobility group box-1 and biomarkers of inflammation in the vitreous from patients with proliferative diabetic retinopathy | Q35108807 |
| | Multiplex bead analysis of vitreous and serum concentrations of inflammatory and proangiogenic factors in diabetic patients | Q36511716 |
| | Up-regulation of vascular cyclooxygenase-2 in diabetes mellitus. | Q36749155 |
| | AGE/RAGE produces endothelial dysfunction in coronary arterioles in type 2 diabetic mice | Q36844673 |
| | Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor | Q36983772 |
| | Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1). | Q37081039 |
| | Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy | Q37084522 |
| | Immunological mechanisms in the pathogenesis of diabetic retinopathy | Q37109989 |
| | Endothelial cell COX-2 expression and activity in hypoxia | Q38308489 |
| | Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule | Q38585899 |
| | Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis | Q40591208 |
| | Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells | Q40686939 |
| | SDF-1 is both necessary and sufficient to promote proliferative retinopathy. | Q40743408 |
| | Monocyte chemotactic protein-1 in proliferative vitreoretinal disorders. | Q41113597 |
| | Expression of high-mobility groups box-1/receptor for advanced glycation end products/osteopontin/early growth response-1 pathway in proliferative vitreoretinal epiretinal membranes. | Q42619210 |
| | Hmgb1 promotes wound healing of 3T3 mouse fibroblasts via RAGE-dependent ERK1/2 activation. | Q42827924 |
| | Expression of advanced glycation end products and related molecules in diabetic fibrovascular epiretinal membranes | Q43071982 |
| | HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells | Q43158876 |
| | Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus | Q43758841 |
| | Inducible nitric oxide synthase and vascular endothelial growth factor are colocalized in the retinas of human subjects with diabetes | Q44789026 |
| | A central role for inflammation in the pathogenesis of diabetic retinopathy | Q44961996 |
| | Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas | Q45056298 |
| | High mobility group 1 B-box mediates activation of human endothelium | Q45182292 |
| | Gene therapy via blockade of monocyte chemoattractant protein-1 for renal fibrosis. | Q45873944 |
| | The role of high mobility group box1 in pulmonary fibrosis | Q46623149 |
| | High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells | Q46783850 |
| | Cytokines in the vitreous of patients with proliferative diabetic retinopathy | Q46851731 |
| | Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. | Q47324915 |
| | Gelatinase B in proliferative vitreoretinal disorders | Q47914078 |
| | Production and Activation of Matrix Metalloproteinase-2 in Proliferative Diabetic Retinopathy | Q47952325 |
| | Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. | Q54564514 |
| | Diabetic retinopathy | Q57232786 |
| | Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders | Q57584307 |
| | The activated form of gelatinase B/matrix metalloproteinase-9 is associated with diabetic vitreous hemorrhage | Q57584366 |
| | High-Mobility Group Box 1 Activates Integrin-Dependent Homing of Endothelial Progenitor Cells | Q58816226 |
| | Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | Q62019449 |
| | Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy | Q70962898 |
| | IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis | Q73160807 |
| | Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus | Q78040840 |
| | Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy | Q79450388 |
| | Inhibition of caspase-1/interleukin-1beta signaling prevents degeneration of retinal capillaries in diabetes and galactosemia | Q79456121 |
| | Expression of cyclo-oxygenase-2 and downstream enzymes in diabetic fibrovascular epiretinal membranes | Q79706914 |
| | Gene expression of tumor angiogenesis dissected: specific targeting of colon cancer angiogenic vasculature | Q79775042 |
| | Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells | Q80217129 |
| | SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells | Q80396461 |
| | Critical role of inducible nitric oxide synthase in degeneration of retinal capillaries in mice with streptozotocin-induced diabetes | Q80510725 |
| | Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A | Q80894668 |
| | Determination of vitreous interleukin-1 (IL-1) and tumour necrosis factor (TNF) levels in proliferative diabetic retinopathy | Q81473347 |
| | Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity | Q82117666 |
| | Relationship between prostaglandin E2 and vascular endothelial growth factor (VEGF) in angiogenesis in human vascular endothelial cells | Q83228101 |
| | Circulating bone-marrow-derived endothelial precursor cells contribute to neovascularization in diabetic epiretinal membranes | Q84572653 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | inflammation | Q101991 |
| P304 | page(s) | 70-74 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Middle East African Journal of Ophthalmology | Q6841320 |
| P1476 | title | Role of inflammation in the pathogenesis of diabetic retinopathy | |
| P478 | volume | 19 | |